The impact of aging on cancer vaccination

Current Opinion in Immunology

Volumn 23, Issue 4, 2011, Pages 555-560

  Gravekamp, Claudia ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYCLOOXYGENASE 2; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; AGING; ANTIGEN PRESENTING CELL; BONE MARROW CELL; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CYTOTOXICITY; HUMAN; IMMUNOREACTIVITY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; MACROPHAGE; MICROENVIRONMENT; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; ANTIGENS, CD28; CANCER VACCINES; DENDRITIC CELLS; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY, ACTIVE; KILLER CELLS, NATURAL; LYMPHOKINES; LYMPHOPENIA; MAMMARY NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; MICE; NATURAL KILLER T-CELLS; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; VACCINATION; VACCINES, DNA;

EID: 80052353920     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.05.003     Document Type: Review

References (54)

1. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902.
2. McElhaney J.E., Meneilly G.S., Lechelt K.E., Bleackley R.C. Split-virus influenza vaccines: do they provide adequate immunity in the elderly?. Gerontology 1994, 49:M37-M43.
3. Gravekamp C. The importance of the age factor in cancer vaccination at older age. Cancer Immunol Immunother 2009, 58:1969-1977.
4. Miller R.A. The aging immune system: primer and prospectus. Science 1996, 273:70-74.
5. Utsuyama M., Hirokawa K., Kurashima C. Differential age-change in the number of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech Ageing Dev 1992, 63:57-68.
6. Tamir A., Eisenbraun M.D., Garcia G.G. Age-dependent alterations in the assembly of signal transduction complexes at the site of T cell/APC interaction. J Immunol 2000, 165:1243-1251.
7. Wack A., Cossarizza A., Heltai S. Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol 1998, 10:1281-1288.
8. Effros R.B. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 2006, 7:599-604.
9. Effros R.B. Replicative senescence of CD8 T cells: effect on human aging. Exp Gerontol 2004, 39:517-524.
10. Filaci G., Fravega M., Negrini S. Nonantigen-specific CD8+ suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T cell proliferation and CTL function. Hum Immunol 2004, 65:142-156.
11. McElhaney J.E., Meneilly G.S., Lechelt K.E. Split-virus influenza vaccines: do they provide adequate immunity in the elderly?. Gerontology 1994, 49:M37-M43.
12. Quyang Q., Cicek G., Westendorp R.G.J. Reduced IFNγ production in elderly people following in vitro stimulation with influenza vaccine and endotoxin. Mech Ageing Dev 2000, 121:131-137.
13. Gomez C.R., Nomelli V., Faunce D.E., Kovacs E.J. Innate Immunity and Aging. Exp Gerontol 2008, 43:718-728.
14. Ogata K., Yokose N., Tamura H., An E., Nakamura K., Dan K., Nomura T. Natural Killer cells in the late decades of human life. Clin Immunol Immunopathol 1997, 84:269-275.
15. Ravaglia G., Forti P., Maioli F., Bastagli L., Facchini A., Mariani E., Savarino L., Sassi S., Cucinotta D., Lenaz G. Effects of micronutrient status on natural killer immune function in healthy free-living subjects aged >90 y. Am J Clin Nutr 2000, 71:590-598.
16. Emoto M., Kaufmann Liver NKT cells: an account of heterogeneity. Trends Immunol 2003, 24:364-369.
17. Mocchegiani E., Malavolta M. NK and NKT cell functions in immunosenescence. Aging Cell 2004, 177-184.
18. Plackett T.P., Boehmer E.D., Faunce D.E., Kovacs E.J. Aging and innate immune cells. J Leukoc Biol 2004, 76:199-291.
19. Biron C.A., Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001, 13:458-464.
20. Sauerwein-Teissl M., Schonitzer D., Grubeck-Loebenstin B. Dendritic cell responsiveness to stimulation with influenza vaccine is unimpaired in old age. Exp Gerontol 1998, 33:625-631.
21. Sprecher E., Becker Y., Kraal G. Effect of aging on the epidermal dendritic cell population in C57Bl/6 J mice. J Invest Dermatol 1990, 94:247-253.
22. Bella D., Bierti L., Presicce P. Peripheral blood dendritic cells and monocytes are differentially regulated in the elderly. Clin Immunol 2007, 122:220-228.
23. Agrawal A., Agrawal S., Cao J.N. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinisitide 3-kinase-signaling pathway. J Immunol 2007, 178:6912-6922.
24. + lymphocytes by autologous tumor cells. Int J Cancer 1990, 46:152-154.
25. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
26. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009, 182:4499-4506.
27. Dumitriu I.E., Dunbar D.R., Howie S.E., Sethi T., Gregory C.D. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 2009, 182:2795-2807.
28. Sica A., Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007, 117:1155-1166.
29. Grizzle W.E., Xy X., Zhang S., Stockard C.R., Liu C., Yu S., Wang J., Mountz J.D., Zhang H.G. Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. Mech Ageing Dev 2007, 128:672-680.
30. Shimizu J., Yamzaki S., Sakaguchi S. Induction of tumor immunity by removing CD4+CD25+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999, 163:5211-5218.
31. Tanaka H., Tanaka J., Kjaergaard J. Depletion of CD4+CD25+ regulatory T cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother 2002, 25:207-217.
32. Chen A., Liu S., Park D. Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adaptive T cell transfer. Cancer Res 2007, 67:1291-1298.
33. Gregg R., Smith C.M., Clark F.J., Dunnio D., Khan N., Chakraverty R., Nayak L., Moss P.A. The number of human peripheral blood CD4+CD25high regulatory T cells increases with age. Clin Exp Immunol 2005, 140:540-546.
34. Mocikat R., Braumuller H., Gumy A. Natural killer cells activated by MHC Class Il targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003, 19:561-569.
35. Guerra N., Tan Y.X., Joncker N.T., Choy A., Gallardo F., Xiong N., Knoblaugh S., Cado D., Greenberg N.R., Raulet D.H. NKG2D-defiecient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008, 28:571-580.
36. Smyth M.J., Crowe N.Y., Godfrey D.A. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int Immunol 2000, 13:459-463.
37. Turner J.G., Rakhmilevich A.L., Burdelya L., Neal Z., Imboden M., Sondel P., Yu H. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells. J Immunol 2001, 166:89-94.
38. Hallett W.H.D., Ames E., Motarjemi M., Barao I., Shankar A., Tamang D.L., Sayers T.J., Hudig D., Murphy W.J. Sensitization of tumor cells to NK cell-mediated killing by proteosome inhibition. J Immunol 2008, 180:163-170.
39. Castro F., Leal B., Denny A., Bahar R., Lampkin S., Reddick R., Lu S., Gravekamp C. Vaccination with Mage-b DNA induces CD8 T cell responses at young but not at old age in mice with metastatic breast cancer. Br J Cancer 2009, 101:1329-1337.
40. Nakui M., Ohta A., Sekimoto M., Sato M., Iwakabe K., Yahata T., Kitamura H., Koda T., Kawano T., Makuuchi H. Potentiation of antitumor effect of NKT cell ligand alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells. Clin Exp Metastasis 2000, 18:147-153.
41. Nakagawa R., Serizawa I., Motoki K., Sato M., Ueno H., Iijima R., Nakamura H., Shimosaka A., Koezuka Y. Anti-tumor activity of alpha-galactosylceramide, KRN7000, in mice with melanoma B16 hepatic metastases and immunological study of tumor-infiltrating cells. Oncol Res 2000, 12:51-58.
42. Giaccone G., Punt C.J., Ando Y., Ruijter R., Nishi N., Peters M., von Blomberg B.M., Scheper R.J., van der Vliet H.J., van den Eertwegh A.J., et al. A phase I study of natural killer T ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002, 8:3702-3709.
43. Muss H.B. Factors used to select adjuvant therapy of breast cancer in the United States: an overview of age, race, and socioeconomic status. J Natl Cancer Inst Monogram 2001, 30:52-55.
44. Provinciali M., Argentati K., Tibaldi A. Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice. Gene Ther 2000, 7:624-632.
45. Provinciali M., Smorlesi A., Donnini A. Low effectiveness of DNA vaccination against HER2/neu in aging. Vaccine 2003, 21:843-848.
46. Lustgarten J., Dominguez A.L., Thomas M. Aged mice develop protective anti-tumor responses with appropriate costimulation. J Immunol 2004, 173:4510-4515.
47. Sharma S., Domiguez A.L., Lustgarten J. Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol 2006, 41:78-84.
48. Grolleau-Julius A., Abernathy L., Harning E., Yung R.L. Mechanisms of murine dendritic cell antitumor dysfunction in aging. Cancer Immunol Immunother 2008, 10.1007/s00262-008-0636-9.
49. Kim S.H., Castro F., Paterson Y., Gravekamp C. High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action. Cancer Res 2009, 69:5860-5866.
50. Lechner M.G., Epstein A.L. A new mechanism for blocking Myeloid-derived suppressor cells by CpG. Clin Cancer Res 2011, 17:1645-1648.
51. Maletto B., Ropolo A., Moron V., Pistoresi-Palencia M.C. CpG-DNA stimulates cellular and humoral immunity and promotes TH1 differentiation in aged BALB/C mice. J Leukoc Biol 2002, 72:447-454.
52. Stacy S., Infante A.J., Wall K. Recall immune memory: a new tool for generating late onset autoimmune myasthenia gravis. Mech Ageing Dev 2003, 124:931-940.
53. Tan J.T., Dudl E., LeRoy E. IL-7 is critical for homeostatic proliferation and survival of naïve T cells. PNAS 2001, 98:8732-8737.
54. Grillot-Courvalin C., Goussard S., Corvalin P. Bacterial vectors for delivering gene and anticancer therapies. Microbe 2011, 6.